An in vitro study found that BM-MSCs may inhibit the proliferation of HSCs and promote its apoptosis by inhibiting TGF-β/Smad pathway, thus reducing the degree of liver fibrosis [66]. Here, TGFB1 is linked to Hepatic fibrosis.